AMGEN $102.18

down -3.45


20/5/2013 04:20 PM  |  NASDAQ : AMGN  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 48% - AMGN has outperformed the S&P 500 by 19%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  2. Pharma Effort to Protect Biologic Drugs Beyond Patents Runs Into ...

    YCharts
  3. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  4. Amgen Phase 3 Trial of Neulasta in Patients with Colorectal Cancer ...

    Benzinga
  5. Watch This Legislation Get Smothered: Bill to Rescind Amgen's $500 ...

    YCharts
  6. Enbrel Drives Amgen Sales

    Investors Business Daily
  7. Amgen Q4 Sales, 2013 Guidance Modestly Beat Estimates

    Investors Business Daily
  8. Earnings Scheduled For January 23, 2013

    Benzinga
  9. Sometimes Republicans and Democrats Agree -- Like on Lining ...

    YCharts
  10. UPDATE: Credit Suisse Downgrades Amgen to Neutral; Upgrade ...

    Benzinga
  11. Benzinga's Top Downgrades

    Benzinga
  12. Earnings Expectations for the Week of January 21

    Benzinga
  13. Amgen

    Investors Business Daily
  14. Amgen

    Investors Business Daily
  15. Amgen Says Top-Line Results from Phase 3 Aranesp RED-HF Trial Did ...

    Benzinga
  16. Amgen's Dividend Policy Has Ignited Its Stock

    GuruFocus
  17. 5 Key Stock Moves From JPMorgan Health Care Confab

    Investors Business Daily
  18. Eylea Sales Hurt Regeneron

    Investors Business Daily
  19. Medtech Stocks Moving As Conference Makes Waves

    Investors Business Daily
  20. Medtech Stocks Moving As Conference Makes Waves

    Investors Business Daily
  21. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  22. Pfizer's Anti-Rheumatoid Arthritis Pill, Potential Blockbuster, ...

    YCharts
  23. Patent Victory Gives AstraZeneca Time to Develop New Drugs: Bad News?

    YCharts
  24. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  25. FDA Says Amgen to Pay $762M to Resolve Criminal Liability

    Benzinga
  26. With Influence Like This, You'd Expect Pharma Stocks to Do Better

    YCharts
  27. From Earlier: Amgen Takes Third License for Rights to Use ...

    Benzinga
  28. Amgen in $762 mil settlement

    Investors Business Daily
  29. Amgen To Pay $762M To Settle Drug Misbranding Case

    Investors Business Daily
  30. Big Cap 20: Biogen, HCA Are Finalizing Bases

    Investors Business Daily
  31. Big Cap 20: Biogen, Comcast Are Finalizing Bases

    Investors Business Daily
  32. Why Some Companies Are Not Accelerating Dividends

    FOXBusiness
  33. The Best Stocks With Dividend Growth From Last Week

    GuruFocus
  34. Amgen Appoints Robert A. Bradway Chairman of the Board Of Directors

    Benzinga
  35. Amgen

    Investors Business Daily
  36. Dividend-Payer Amgen Is Hitting New Highs Again

    Investors Business Daily
  37. UPDATE: Amgen Raises Qtr. Dividend from $0.36 to $0.47/Share, Adds ...

    Benzinga
  38. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga
  39. Amgen buys DeCode Genetics

    Investors Business Daily
  40. IBD Big Cap 20 Analysis: 5 Promising Stocks From List

    Investors Business Daily
  41. Amgen Buying DeCode Genetics To Find Targeted Drugs

    Investors Business Daily
  42. Amgen Buys Decode Genetics for $415M in Cash

    FOXBusiness
  43. Amgen, Gilead, Regeneron Among 7 Best Biotech Stocks

    Investors Business Daily
  44. ResMed, First American, Amgen Sketch New Bases

    Investors Business Daily
  45. Apple, Michael Kors, Visa, eBay: Larry Puglia's Bets

    Investors Business Daily
  46. Qihoo, Visa Among 5 Top Stocks With Bolting RS Lines

    Investors Business Daily
  47. Comcast, Regeneron, Biogen Idec Spur New Products

    Investors Business Daily
  48. Deere, Sherwin-Williams Lead Big-Cap Growth Stocks

    Investors Business Daily
  49. More Mega-Cap ETFs Your Broker Forgot to Mention

    Benzinga
  50. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  51. Why Ted Weschler Keeps Buying DaVita (DVA)

    GuruFocus
  52. Amgen drug results promising

    Investors Business Daily
  53. Amgen Inc. Reports Operating Results (10-Q)

    GuruFocus
  54. Amgen Cholesterol-Fighter Shows Promise, Shares Rise

    Investors Business Daily
  55. Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial Did Not Meet Primary Endpoint

    Benzinga
  56. Watson Pharma Starts New Era As Generic Drug Titan

    Investors Business Daily
  57. My 5 Favorite Health Care Growth Picks of the Next 5 Years

    GuruFocus
  58. Best & Worst ETFs & Mutual Funds: Health Care Sector

    Benzinga
  59. Cabela's Sinks Sharply Below Support; Catamaran Firms

    Investors Business Daily
  60. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga
  61. S&P Likes a Trio of Biotech ETFs

    Benzinga
  62. UPDATE: Oppenheimer Raises PT to $89 on Amgen

    Benzinga
  63. UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Amgen

    Benzinga
  64. IBD 50: Alexion Earnings Beat Estimates; Stock Up

    Investors Business Daily
  65. Top 5 Big Cap Stocks Led By Michael Kors, Alexion

    Investors Business Daily
  66. Amgen, Gilead Q3 Profits Top

    Investors Business Daily
  67. Alexion Earnings Expected To Grow, But Stock Slides

    Investors Business Daily
  68. Amgen, PulteGroup Among Top 5 Stocks With Bolting RS Lines

    Investors Business Daily
  69. Stock Market Futures Slip On Weak Q3 Results

    Investors Business Daily
  70. Amgen, 4 Other Stock Leaders Outperforming S&P 500

    Investors Business Daily
  71. Big Caps Taking Heat; Alexion Breakout Crumbling

    Investors Business Daily
  72. UPDATE: Deutsche Bank Upgrades Amgen to Buy on EPS Growth, ...

    Benzinga
  73. Gilead, Amgen Earnings To Launch Busy Biotech Week

    Investors Business Daily
  74. Week Ahead: FOMC Meeting and Earnings

    FOXBusiness
  75. Brian Rogers' Highest Sells: Kimberly-Clark, Pinnacle West Capital ...

    GuruFocus
  76. Are Amgen Option Traders Switching Sides?

    By SchaeffersResearch
  77. Medical, Cable, Credit Card Stocks Top IBD Big Cap 20

    Investors Business Daily
  78. Amgen Presents Data from Several Prolia Studies

    Benzinga
  79. Many Stocks Dip In Weak Trade Amid Market Correction

    Investors Business Daily
  80. Puts are popular on AMGN, while calls dominate the action on JPM ...

    By SchaeffersResearch
  81. Alexion, Amgen Among Top 5 Big-Cap Medical Leaders

    Investors Business Daily
  82. Several Big Cap 20 Stocks Hit New Highs, In Buy Area

    Investors Business Daily
  83. 52-Week High Companies: AMGN, CBE, FISV, NEWS, ACE

    GuruFocus
  84. Stock Leaders Cirrus Logic, Amgen Set New Buy Points

    Investors Business Daily
  85. Benzinga's Top Initiations

    Benzinga
  86. Short Interest in Biotech Firms Resumes (BIIB, GILD, ILMN, REGN)

    Benzinga
  87. Alexion, Visa, Others Holding In Possible Buy Ranges

    Investors Business Daily
  88. FDA Approves New Indication for Prolia

    Benzinga
  89. Celgene's Drug Pipeline News Soothes Investor Worries

    Investors Business Daily
  90. Weekly Top Insider Sells: COF, GOOG, AMGN, CRM and FIS

    GuruFocus
  91. Stocks Continue Post QE3 Rally

    At Market Intelligence Center
  92. Amgen Bounces Back On Strong 2012 Performance

    Investors Business Daily
  93. Short Sellers Shy Away from Biotech Firms

    Benzinga
  94. Stock Futures Point to Higher Open Ahead Fed Meeting with Apple ...

    At Market Intelligence Center
  95. Luxury Brand Kors, Biotechs Dominate Daily Screen

    Investors Business Daily
  96. Kors, Apple, Big Names On Big Cap Screen Of the Day

    Investors Business Daily
  97. Amgen Doing Fine Despite Challenges

    Investors Business Daily
  98. Big Cap 20: More Stocks Flirting With Entries

    Investors Business Daily
  99. Apple, Google, Western Digital Among Big Cap Leaders

    Investors Business Daily
  100. Amgen Inc. Reports Operating Results (10-Q)

    GuruFocus
People viewing AMGN also viewed: , , , , , ,
Marketplace
Trading Center